| Betterchem |

|
|
| FDA approval activities
for this prescription drug:
Dacarbazine for Injection USP, 200 mg/vial, Faulding Pharmaceutical Co. ANDA 75-940 10/18/01 4/16/03 Dacarbazine for Injection USP, 500 mg/vial, Bedford ANDA 75-812/S3 10/31/02 Dacarbazine for Injection USP, 200 mg/vial, Bedford ANDA 75-812 6/15/01 6/26/01 Dacarbazine for Injection USP, 100 mg/vial & 200 mg/vial American Pharmaceutical Partners, ANDA 75-371 8/27/99 9/2/99 Dacarbazine for Injection USP, 200 mg/vial, Gensia Sicor ANDA 75-259 DACARBAZINE Injection 100MG/VIAL DACARBAZINE AM PARTNERS 075371 DACARBAZINE Injection 200MG/VIAL DACARBAZINE AM PARTNERS 017575 DACARBAZINE Injection 100MG/VIAL DTIC-DOME BAYER 017575 DACARBAZINE Injection 200MG/VIAL DTIC-DOME BAYER 075812 DACARBAZINE Injection 200MG/VIAL DACARBAZINE BEDFORD 075812 DACARBAZINE Injection 500MG/VIAL DACARBAZINE BEDFORD 075940 DACARBAZINE Injection 200MG/VIAL DACARBAZINE FAULDING 075259 DACARBAZINE Injection 200MG/VIAL DACARBAZINE GENSIA SICOR 075259 DACARBAZINE Injection 500MG/VIAL DACARBAZINE GENSIA SICOR |
|
© 2009 Betterchem.com
|